GGrantIndex
← Leaderboards

Elias Lolis

Yale University

$7,866,115
Attributed
$9,273,732
Total exposure
14
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,273,732 · 14

By mechanism

R01$7,097,275 · 4
R21$2,151,895 · 5
P41$24,562 · 5

Top collaborators

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Small Molecule

Research focus

Small MoleculeStructureProteinsSignal TransductionMalignant NeoplasmsCellsReceptorIn VivoComplexPhysiologicalMutantChemokine ReceptorMediatingBaseCatalytic DomainDesignBinding (Molecular Function)AgonistRegulationChemokinePlayMouse ModelG-Protein-Coupled ReceptorsSite

Grant awards (32)

MKP5 allostery in MAPK regulation and signaling in the heart$579,656
R01 · FY2025 · HL
MKP5 allostery in MAPK regulation and signaling in the heart$584,478
R01 · FY2024 · HL
MKP5 allostery in MAPK regulation and signaling in the heart$604,781
R01 · FY2023 · HL
Humanizing CXCL13 and CXCR5 in mice$191,851
R21 · FY2023 · CA · contact PI
MKP5 allostery in MAPK regulation and signaling in the heart$620,333
R01 · FY2022 · HL
Humanizing CXCL13 and CXCR5 in mice$234,919
R21 · FY2022 · CA · contact PI
Adoptive Cellular Therapy of T Cell Lymphoma$230,220
R21 · FY2022 · CA
Adoptive Cellular Therapy of T Cell Lymphoma$195,766
R21 · FY2021 · CA
Targeting CXCR5 for angioimmunoblastic T-cell lymphoma$175,881
R21 · FY2017 · CA · contact PI
Targeting CXCR5 for angioimmunoblastic T-cell lymphoma$212,223
R21 · FY2016 · CA · contact PI
Structure of the Chemokine Receptor CXCR3$208,125
R21 · FY2015 · AI · contact PI
Structure of the Chemokine Receptor CXCR3$249,750
R21 · FY2014 · AI · contact PI
Regulation of CXCR4 by cognate and non-cognate ligands$381,186
R01 · FY2013 · AI · contact PI
Regulation of CXCR4 by cognate and non-cognate ligands$405,516
R01 · FY2012 · AI · contact PI
Regulation of CXCR4 by cognate and non-cognate ligands$399,097
R01 · FY2011 · AI · contact PI
Crystal Structures of CXCR4 complexed to CXCL12$204,910
R21 · FY2011 · AI · contact PI
Regulation of CXCR4 by cognate and non-cognate ligands$403,128
R01 · FY2010 · AI · contact PI
Functional and Structural Studies of CD74 Activation$390,178
R01 · FY2010 · AI · contact PI
Crystal Structures of CXCR4 complexed to CXCL12$248,250
R21 · FY2010 · AI · contact PI
MIF ENZYMATIC INHIBITION$2,682
P41 · FY2010 · RR · contact PI
Regulation of CXCR4 by cognate and non-cognate ligands$407,200
R01 · FY2009 · AI · contact PI
Functional and Structural Studies of CD74 Activation$394,118
R01 · FY2009 · AI · contact PI
Functional and Structural Studies of CD74 Activation$394,019
R01 · FY2008 · AI · contact PI
Functional and Structural Studies of CD74 Activation$400,538
R01 · FY2007 · AI · contact PI
Functional and Structural Studies of CD74 Activation$412,188
R01 · FY2006 · AI · contact PI
INHIBITION OF MACROPHAGE MIGRATION INHIBITORY FACTOR$11,105
P41 · FY2006 · RR · contact PI
SELENO-METHIONINE DERIVATIVE OF THE KH3 DOMAIN OF THE FUSE BINDING PROTEIN$3,332
P41 · FY2006 · RR · contact PI
ANCYLOSTOMA CEYLANICUM MIF$3,332
P41 · FY2006 · RR · contact PI
KH3 DOMAIN OF FUSE BINDING PROTEIN COMPLEXED TO SINGLE-STRANDED DNA$4,111
P41 · FY2005 · RR
SDF-1A AND MIP-II INTERACTIONS WITH CHEMOKINE RECEPTORS$247,421
R01 · FY2002 · AI
SDF-1A AND MIP-II INTERACTIONS WITH CHEMOKINE RECEPTORS$240,217
R01 · FY2001 · AI
SDF-1A AND MIP-II INTERACTIONS WITH CHEMOKINE RECEPTORS$233,221
R01 · FY2000 · AI